Dosing Information Not Available in Provided Evidence
I cannot provide a definitive recommendation for the specific dosing of eperisone and Phos-NaK administered three times daily for only one day, as the provided evidence does not contain information about this particular regimen or about "Phos-NaK" as a medication.
What the Evidence Shows About Eperisone
For eperisone, the standard dosing is 50 mg three times daily (150 mg total daily dose) for treatment durations of 7-14 days, not single-day administration 1, 2, 3, 4.
Standard Eperisone Dosing:
- Initial and maintenance dose: 50 mg three times daily (TID)
- Total daily dose: 150 mg/day divided into three doses
- Typical treatment duration: 7-14 days for acute musculoskeletal conditions with low back pain 2, 3, 4
- Administration: Oral, with or without food 1
The FDA labeling indicates taking 2 caplets every 6 hours with a maximum of 8 caplets in 24 hours for adults and children ≥12 years 1. However, this appears to reference a combination product containing acetaminophen and aspirin, not pure eperisone 1.
Critical Gap: "Phos-NaK" Product
No evidence was provided regarding "Phos-NaK" dosing, formulation, or clinical use. The only phosphate-related evidence pertains to intravenous phosphate repletion in ICU patients with hypophosphatemia (15 mmol sodium phosphate infused over 2 hours) 5, which is unrelated to your question.
Clinical Caveat
Single-day dosing of eperisone has not been studied or validated in the provided evidence. All clinical trials demonstrating efficacy used multi-day regimens (minimum 7 days) 2, 3, 4. A one-day TID regimen would provide only 3 doses (150 mg total), which has no established clinical benefit for musculoskeletal conditions.
If you are asking about a specific proprietary combination product or a different clinical context, please clarify the indication and product formulation to receive accurate dosing guidance.